Next Article in Journal
Physical Activity and Post-Transcriptional Regulation of Aging Decay: Modulation of Pathways in Postmenopausal Osteoporosis
Previous Article in Journal
Reply to Vrijdag et al. Comment on “Mankowska et al. Critical Flicker Fusion Frequency: A Narrative Review. Medicina 2021, 57, 1096”
 
 
Reply published on 13 June 2022, see Medicina 2022, 58(6), 793.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213

1
Neuroscience Department, Medical Research Group of Egypt, Zagazig 44523, Egypt
2
Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan
3
Arab Council for Health Specializations, Sana’a 11274, Yemen
4
Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt
5
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK
*
Author to whom correspondence should be addressed.
Medicina 2022, 58(6), 766; https://doi.org/10.3390/medicina58060766
Submission received: 14 May 2022 / Accepted: 30 May 2022 / Published: 6 June 2022
(This article belongs to the Topic Mechanisms and Treatments of Neurodegenerative Diseases)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

We read with interest the article by Abbas et al. [...]

Share and Cite

MDPI and ACS Style

Aljabali, A.; Abdo, M.; Negida, A. Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213. Medicina 2022, 58, 766. https://doi.org/10.3390/medicina58060766

AMA Style

Aljabali A, Abdo M, Negida A. Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213. Medicina. 2022; 58(6):766. https://doi.org/10.3390/medicina58060766

Chicago/Turabian Style

Aljabali, Ahmed, Maha Abdo, and Ahmed Negida. 2022. "Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213" Medicina 58, no. 6: 766. https://doi.org/10.3390/medicina58060766

APA Style

Aljabali, A., Abdo, M., & Negida, A. (2022). Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213. Medicina, 58(6), 766. https://doi.org/10.3390/medicina58060766

Article Metrics

Back to TopTop